* Guardion Health Sciences Inc GHSI.OQ GHSI.O is
expected
to show a fall in quarterly revenue when it reports results on
August 9 (estimated).
* The Houston Texas-based company is expected to report a
15.0% decrease in revenue to $2.784 million from $3.28 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for Guardion Health
Sciences
Inc is for a loss of 93 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Guardion
Health
Sciences Inc is $26, above its last closing price of $7.84.
This summary was machine generated August 7 at 18:34 GMT. All
figures in US dollars unless otherwise stated